Literature DB >> 16699464

A divalent human leukocyte antigen-B7 fusion-protein up-regulates CD25 and CD69 in alloreactive CD8+ T cells bypassing CD28 costimulation.

Uta Rickert1, Judith Welke, Dirk Behrens, Nicholas Zavazava.   

Abstract

BACKGROUND: T cells recognize major histocompatibility complex (MHC) molecules and their cryptic antigenic peptides on antigen-presenting cells and are generally triggered to proliferate, and when sufficient, co-stimulation is available. In soluble form, monomeric MHC molecules can induce apoptosis, anergy, or decreases of the T-cell receptor (TCR).
METHODS: A dimeric fusion protein of the human leukocyte antigens (HLA)-B7 was molecularly engineered and expressed in a B-cell line to allow secretion. Alloreactive T cells were generated according to the standard protocol.
RESULTS: A dimer of approximately 160 kD was obtained, affinity purified, and used to study T-cell interaction. In immobilized form, this protein efficiently stimulated alloreactive T cells to proliferate and produce interleukin (IL)-2 and interferon (IFN)-gamma in a concentration-dependent manner, up-regulating CD25 and CD69 expression. In contrast, the soluble fusion protein induced T-cell apoptosis.
CONCLUSIONS: The dichotomy in T-cell regulation by a divalent MHC fusion protein warrants the use of MHC multimers as custom-designed immune-regulatory molecules both in transplantation and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699464     DOI: 10.1097/01.tp.0000205770.07196.e6

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  HOXB4 but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cells.

Authors:  Sabrina Bonde; Amy M Dowden; Kun-Ming Chan; William B Tabayoyong; Nicholas Zavazava
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

2.  Soluble MOG35-55/I-A(b) dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells.

Authors:  Yeli Gong; Zhigang Wang; Zhihui Liang; Hongxia Duan; Lichen Ouyang; Qian Yu; Zhe Xu; Guanxin Shen; Xiufang Weng; Xiongwen Wu
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.